Variability of interferon-λ induction and antiviral activity in Nipah virus infected differentiated human bronchial epithelial cells of two human donors

References

1. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A et al. Nipah virus: a recently emergent deadly paramyxovirus. Science 2000; 288:1432–1435 [View Article][PubMed]
   [Google Scholar]
2. Lo MK, Rota PA. The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol 2008; 43:396–400 [View Article][PubMed]
   [Google Scholar]
3. Escaffre O, Borisevich V, Carmical JR, Prusak D, Prescott J et al. Henipavirus pathogenesis in human respiratory epithelial cells. J Virol 2013; 87:3284–3294 [View Article][PubMed]
   [Google Scholar]
4. Escaffre O, Borisevich V, Vergara LA, Wen JW, Long D et al. Characterization of Nipah virus infection in a model of human airway epithelial cells cultured at an air-liquid interface. J Gen Virol 2016; 97:1077–1086 [View Article][PubMed]
   [Google Scholar]
5. Egli A, Santer DM, O'Shea D, Tyrrell DL, Houghton M. The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg Microbes Infect 2014; 3:e51 [View Article][PubMed]
   [Google Scholar]
6. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4:69–77 [View Article][PubMed]
   [Google Scholar]
7. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4:63–68 [View Article][PubMed]
   [Google Scholar]
8. Lazear HM, Nice TJ, Diamond MS. Interferon-λ: immune functions at barrier surfaces and beyond. Immunity 2015; 43:15–28 [View Article][PubMed]
   [Google Scholar]
9. Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo . PLoS Pathog 2008; 4:e1000017 [View Article][PubMed]
   [Google Scholar]
10. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA et al. Role of deficient type III interferon-λ production in asthma exacerbations. Nat Med 2006; 12:1023–1026 [View Article][PubMed]
    [Google Scholar]
11. Mahlakõiv T, Ritz D, Mordstein M, Dediego ML, Enjuanes L et al. Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread. J Gen Virol 2012; 93:2601–2605 [View Article][PubMed]
    [Google Scholar]
12. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR et al. Interferon-λ contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 2008; 4:e1000151 [View Article][PubMed]
    [Google Scholar]
13. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 2010; 84:5670–5677 [View Article][PubMed]
    [Google Scholar]
14. Dietzel E, Kolesnikova L, Sawatsky B, Heiner A, Weis M et al. Nipah virus matrix protein influences fusogenicity and is essential for particle infectivity and stability. J Virol 2015; 90:2514–2522 [View Article][PubMed]
    [Google Scholar]
15. Sauerhering L, Zickler M, Elvert M, Behner L, Matrosovich T et al. Species-specific and individual differences in Nipah virus replication in porcine and human airway epithelial cells. J Gen Virol 2016; 97:1511–1519 [View Article][PubMed]
    [Google Scholar]
16. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci USA 2005; 102:10652–10657 [View Article][PubMed]
    [Google Scholar]
17. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 2005; 436:401–405 [View Article][PubMed]
    [Google Scholar]
18. Duong FH, Trincucci G, Boldanova T, Calabrese D, Campana B et al. IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies. J Exp Med 2014; 211:857–868 [View Article][PubMed]
    [Google Scholar]
19. Sarkis PT, Ying S, Xu R, Yu XF. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-α. J Immunol 2006; 177:4530–4540 [View Article][PubMed]
    [Google Scholar]
20. Schlaak JF, Hilkens CM, Costa-Pereira AP, Strobl B, Aberger F et al. Cell-type and donor-specific transcriptional responses to interferon-α. Use of customized gene arrays. J Biol Chem 2002; 277:49428–49437 [View Article][PubMed]
    [Google Scholar]
21. Gray TE, Guzman K, Davis CW, Abdullah LH, Nettesheim P. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol 1996; 14:104–112 [View Article][PubMed]
    [Google Scholar]
22. Freitag TC, Maisner A. Early activation of primary brain microvascular endothelial cells by Nipah virus glycoprotein-containing particles. J Virol 2015; 90:2706–2709 [View Article][PubMed]
    [Google Scholar]
23. Krutzik PO, Nolan GP. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 2003; 55:61–70 [View Article][PubMed]
    [Google Scholar]